José Alberto San Román

ORCID: 0000-0003-0764-0839
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Cardiac Structural Anomalies and Repair
  • Antimicrobial Resistance in Staphylococcus
  • Aortic Disease and Treatment Approaches
  • Cardiovascular Function and Risk Factors
  • Coronary Interventions and Diagnostics
  • Streptococcal Infections and Treatments
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Infectious Aortic and Vascular Conditions
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 Clinical Research Studies
  • Aortic aneurysm repair treatments
  • Heart Failure Treatment and Management
  • Pulmonary Hypertension Research and Treatments
  • Advanced MRI Techniques and Applications
  • Congenital Heart Disease Studies
  • Mesenchymal stem cell research
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management

Hospital Clínico Universitario de Valladolid
2016-2025

Centro de Investigación Biomédica en Red
2017-2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2017-2025

Universidad de Valladolid
2001-2025

Instituto de Salud Carlos III
2017-2024

Universidad de Santiago de Chile
2024

Comunidad de Madrid
2023

Centre for Biomedical Network Research on Rare Diseases
2022

Clinique Pasteur
2017-2021

Institute of Cardiology
2021

The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient, where necessary patient's guardian or carer.It is also professional's verify rules regulations...

10.1093/eurheartj/ehp285 article EN European Heart Journal 2009-08-27

Bone marrow mononuclear cells (BMCs) from 20 patients with extensive reperfused myocardial infarction (MI) were used to assess their regenerative capability “in vitro” and effect on postinfarction left ventricular (LV) remodeling. Human BMCs labeled, seeded top of cryoinjured mice heart slices, cultured. showed tropism for ability graft into the damaged mouse cardiac tissue and, after 1 week, acquired a cardiomyocyte phenotype expressed proteins, including connexin43. In clinical trial,...

10.1161/01.res.0000144798.54040.ed article EN Circulation Research 2004-09-10

Background— The objective of this study was to evaluate the timing, predictive factors, and prognostic value cerebrovascular events (CVEs) after transcatheter aortic valve implantation. Methods Results— included 1061 consecutive patients who underwent implantation with a balloon-expandable (64%) or self-expandable (36%) valve. CVEs were classified as acute (≤24 hours), subacute (1–30 days), late (>30 days). occurred in 54 (5.1%; stroke, 4.2%) within 30 days (acute 54% cases). predictors...

10.1161/circulationaha.112.110981 article EN Circulation 2012-11-14

<h3>Importance</h3> Limited data exist on clinical characteristics and outcomes of patients who had infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR). <h3>Objective</h3> To determine the associated factors, characteristics, TAVR. <h3>Design, Setting, Participants</h3> The Infectious Endocarditis TAVR International Registry included with definite from 47 centers Europe, North America, South America between June 2005 October 2015. <h3>Exposure</h3>...

10.1001/jama.2016.12347 article EN JAMA 2016-09-13

Background— We aimed to determine the incidence, predictors, clinical characteristics, management, and outcomes of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI). Methods Results— This multicenter registry included 53 patients (mean age, 79±8 years; men, 57%) who suffered IE TAVI 7944 a mean follow-up 1.1±1.2 years (incidence, 0.67%, 0.50% within first year TAVI). Mean time from was 6 months (interquartile range, 1–14 months). Orotracheal intubation (hazard...

10.1161/circulationaha.114.014089 article EN Circulation 2015-03-10
Javier Bermejo Raquel Yotti Rocío García‐Orta Pedro L. Sánchez Mario Castaño and 93 more Javier Segovia Pilar Escribano Subías José Alberto San Román Xavier Borrás Joaquín Alonso Javier Botas María G. Crespo‐Leiro Sonia Velasco Antoni Bayés‐Genís Amador López Roberto Muñoz‐Aguilera Eduardo de Teresa José Ramón González‐Juanatey Arturo Evangelista Teresa Mombiela Ana González‐Mansilla Jaime Elı́zaga Javier Martín‐Moreiras José María González‐Santos Eduardo Moreno Escobar Francisco Fernández‐Avilés Javier Bermejo Raquel Yotti Teresa Mombiela Ana González‐Mansilla Jaime Elı́zaga José Antonio García-Robles Esther Pérez David Candelas Pérez del Villar Ricardo Sanz Enrique Gutiérrez María Eugenia Vázquez Ana Mur Yolanda Benito Pablo Martínez‐Legazpi Alicia Gómez‐Barrio Alexandra Vázquez Rocío García‐Orta Inés Uribe Mercedes Freire González Pedro L. Sánchez José María González‐Santos Javier Martín‐Moreiras Antonio Arribas Miguel Lorenzo Alejandro Diego Nieto Mario Castaño Armando Pérez de Prado David Alonso‐Gutiérrez Javier Segovia Manuel Gómez‐Bueno Inés Sayago Silva Miguel Ángel Broc Cavero Pilar Escribano Subías Laura Domínguez Rocío Tello de Meneses María José Caño Carmen Jiménez López-Guarch José Alberto San Román Pedro Mota Xavier Borrás Carmen Amorós Galitó Joaquín Alonso María C. Mora Dolores Mesa Javier Botas Raquel Campuzano María G. Crespo‐Leiro Raquel Marzoa José Cuenca Sonia Velasco Roberto Muñóz Verónica Suberviola Cristina Beltrán Herrera Laura Mora M Sarrión David Vaqueriza Antoni Bayés‐Genís Elena Ferrer José Ramón González‐Juanatey Belén Cid A. Martínez Monzonís Amador López José M Arizón de Prado Marta Santisteban Dolores Mesa Arturo Evangelista David García‐Dorado Eduardo de Teresa Manuel F. Jiménez‐Navarro Fernando Carrasco Chinchilla Eduardo Moreno Escobar Joaquín Alonso

We aimed to determine whether treatment with sildenafil improves outcomes of patients persistent pulmonary hypertension (PH) after correction valvular heart disease (VHD).

10.1093/eurheartj/ehx700 article EN cc-by-nc European Heart Journal 2017-11-14

Abstract Aims The respective roles of oral anticoagulation or antiplatelet therapy following transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international, randomized, open-label, superiority trial comparing apixaban to the standard care. Methods and results After successful TAVI, 1500 patients were randomized (1:1) receive 5 mg (2.5 if impaired renal function concomitant therapy) (n = 749) twice daily, care 751). Randomization was stratified by need for chronic...

10.1093/eurheartj/ehac242 article EN European Heart Journal 2022-04-29

Aims To investigate the clinical features, echocardiographic characteristics, management, and prognostic factors of mortality aorto-cavitary fistulization (ACF) in infective endocarditis (IE). Extension infection aortic valve IE beyond valvular structures may result peri-annular complications with resulting necrosis rupture, subsequent development ACF. Aorto-cavitary communications create intra-cardiac shunts, which further deterioration haemodynamic instability. Methods results In a...

10.1093/eurheartj/ehi034 article EN European Heart Journal 2004-11-30

To compare primary percutaneous coronary intervention (pPCI) and fibrinolysis in very old patients with ST-segment elevation myocardial infarction (STEMI), whom head-to-head comparisons between both strategies are scarce.

10.1093/eurheartj/ehq375 article EN European Heart Journal 2010-10-22

There is no agreement in the best cutoff time to distinguish between early- and late- onset prosthetic valve endocarditis (PVE). Our objectives are define early-onset PVE according microbiological spectrum analyse profile short-term prognosis of this entity.The 172 non-drug users, who were patients with PVE, compared elapsed from surgery among 640 diagnosed 1996 2004. differences occurred within 2 months replacement those accounting 12 months. The proportion coagulase-negative Staphylococci...

10.1093/eurheartj/ehl486 article EN European Heart Journal 2007-01-25

The prognosis of patients with infective endocarditis (IE) remains poor despite the great advances in last decades. One factors closely related to mortality is development septic shock (SS). aim our study was describe profile IE complicated SS, and identify prognostic new-onset SS during hospitalization. We conducted a prospective including 894 episodes diagnosed at three tertiary centres. A backward logistic regression analysis undertaken determine associated development. Multivariable...

10.1093/eurheartj/ehs336 article EN European Heart Journal 2012-10-11

Traumatic spinal cord injury (SCI) induces tissue damage and results in the formation of a cavity that inhibits axonal regrowth. Filling this with growth-permissive substrate would likely promote regeneration repair. Single-walled carbon nanotubes functionalized polyethylene glycol (SWNT-PEG) have been shown to increase length selected neurites vitro. We hypothesized administration SWNT-PEG after experimental SCI will axons into lesion functional recovery hindlimbs. To evaluate hypothesis,...

10.1089/neu.2010.1409 article EN Journal of Neurotrauma 2011-02-09

<h3>Objective</h3> To develop and validate a calculator to predict the risk of in-hospital mortality in patients with active infective endocarditis (IE) undergoing cardiac surgery. <h3>Methods</h3> Thousand two hundred ninety-nine consecutive IE were prospectively recruited (1996–2014) retrospectively analysed. Left-sided who underwent surgery (n=671) form our study population randomised into development (n=424) validation (n=247) samples. Variables statistically significant in-mortality...

10.1136/heartjnl-2016-311093 article EN Heart 2017-04-21

Introduction: Coronavirus disease 2019 (COVID-19) is a systemic characterized by disproportionate inflammatory response in the acute phase. This study sought to identify clinical sequelae and their potential mechanism. Methods: We conducted prospective single-center (NCT04689490) of previously hospitalized COVID-19 patients with without dyspnea during mid-term follow-up. An outpatient group was also evaluated. They underwent serial testing cardiopulmonary exercise test (CPET), transthoracic...

10.3390/jcm10122591 article EN Journal of Clinical Medicine 2021-06-11
Coming Soon ...